APAC Healthcare Weekly (Oct 20)- Eisai, Daiichi Sankyo, Junshi Bioscience, Akeso, Celltrion, Neuren
This insight collates key news in APAC healthcare last week. With the earnings season beginning to unfold along with major pharma and healthcare...
365 Views
The US Biosecure Act: A Boon for Indian CDMO Players?
The Biosecure Act passed by the U.S. House could boost Indian CDMOs as alternative to Chinese biotechs by 2032, leading to potential growth...
588 Views
India: Stock Reclassification & Active Portfolio Management (Dec 2021)
Halfway through the review period, we take a look at stocks that could migrate across the large, mid and small cap segments. With over US$100bn of...
350 Views
Jubilant Group: Related Party Transactions and Accounting Flags
A forensic analysis of Jubilant Group (Promoter Group of Jubilant Foodworks & Jubilant Lifesciences) leads us to certain related party transactions...
572 Views
India Stock Classification Changes - Active Portfolio Churn
Once up a time in India, there was a smorgasbord of mutual fund schemes launched by different fund houses. The same fund house had myriad schemes...
510 Views